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Background Cardiac CT angiography (CTA) has demonstrated high diagnostic accuracy and sensitivity as a non-invasive test to rule out coronary 
artery disease (CAD) among patients with suspected CAD. The prognostic value of a normal CTA has been described in several studies. However, some 
studies were underpowered to detect rare clinical events. There are no prior meta-analyses of this topic.
Methods Design: Systematic review and meta-analysis of observational studies published before September 2009. We included longitudinal 
studies of patients after cardiac CTA to evaluate known or suspected CAD reporting at least three months follow up of major adverse cardiovascular 
events (MACE), death, myocardial infarction, revascularization, and unstable angina. The primary outcome was the negative likelihood ratio (-LR) of 
a major adverse cardiovascular event (death, myocardial infarction, unstable angina, or revascularization) after a normal CTA. Secondary outcomes 
included -LR of death and myocardial infarction.
Results 12 cohort studies of 7662 patients were included with a median follow up of 1.5 years (47, 516 patient years). Mean age was 59 years 
and 62% of patients were male. MACE occurred in 1 % of patients with negative scans, death or MI in 0.9%. MACE occurred in 5.9% of patients with 
positive scans; death or MI in 3.7%. Eight studies provided sufficient data for pooled analysis. The weighted average annualized MACE rate for a 
positive versus a negative CTA was 2.9% vs. 0.2% per year. The pooled -LR for MACE for patients with a negative CTA was 0.15 (95% CI 0.07 - 0.32, 
p < 0.001). Patients with no disease had the lowest adverse event rates and patients with severe disease had the highest. There was no evidence of 
publication bias or statistical heterogeneity.
Conclusions: Several longitudinal studies have evaluated the prognostic value of cardiac CTA. Adverse cardiovascular events among patients 
with negative CTA are very rare and comparable to a baseline risk among healthy patients. For predicting prognosis of adverse clinical events, the 
negative likelihood ratio of a normal CTA is comparable to stress myocardial perfusion scan or stress echocardiography.
